期刊文献+

扎普司特和谷胱甘肽翻转豚鼠离体气管对硝普钠的耐受性 被引量:2

Zaprinast and glutathione reversed sodium nitroprusside tolerance in guinea pig trachea
下载PDF
导出
摘要 上皮完整或去上皮的豚鼠离体气管以300μmol·L-1硝普钠(SNP)预处理1h,使SNP对抗乙醋甲胆碱气管收缩作用的剂量反应曲线右移1.3-1.5倍,最大舒张率下降41%-58%,形成SNP气管松弛作用的耐受性.8-溴环鸟苷酸可模拟SNP在豚鼠离体气管形成的SNP耐受性,谷胱甘肽(1mmol·L-1)及环核苷酸磷酸二酯酶(PDE)Ⅴ抑制剂扎普司特(30μmol·L-1)均可部分翻转SNP的气管松弛作用耐受性,而蛋白合成抑制剂环己酰亚胺(10μmol·L-1)对SNP的耐受性无预防作用.结果表明SNP可产生豚鼠离体气管松弛耐受性,这可能是由于气管平滑肌中环鸟苷酸(cGMP)积聚而下调鸟苷酸环化酶(GC)活性和上调PDEⅤ活性. Tolerance to sodium nitroprusside (SNP) induced relaxation of guinea pig trachea (intact epithelium or epithelial removal) was developed in vitro. Cumulative SNP concentration relaxation studies were initiated 15 min after tissues were contracted with 3 μmol·L 1 methacholine. Pretreatment of isolated guinea pig tracheal chains with 300 μmol·L 1 SNP for 1 h produced a 1.3-1.5 fold rightward shift of the dose response curve. This shift was associated with a 41%-58% reduction in the maximum SNP induced relaxation. Glutathione (1 mmol·L 1 ) and the phosphodiesterase (PDE) Ⅴ inhibitor zaprinast (30 μmol·L 1 ) partially reversed the tolerance to SNP. However, the protein synthesis inhibitor cycloheximide ( 10 μ mol·L 1 ) did not abolish the tolerance to SNP. These results suggest that tolerance to SNP may be due to cGMP accumulation in tracheal smooth muscle cells, which in turn results in down regulation of guanylate cyclase activity and up regulation of PDE Ⅴ activity.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 1997年第4期271-274,共4页 Chinese Journal of Pharmacology and Toxicology
基金 国家自然科学基金
关键词 扎普司特 谷胱甘肽 气管 硝普钠 耐受性 vasodilator agents drug tolerance phosphodiesterase inhibitors sodium nitroprusside glutathione trachea
  • 相关文献

参考文献3

二级参考文献4

  • 1周伟琳,中国药理学与毒理学杂志,1996年,10卷,196页
  • 2周汉良,生理科学进展,1995年,26卷,213页
  • 3周汉良,J Pharmacol Exp Ther,1992年,261卷,1260页
  • 4魏尔清,药学学报,1984年,19卷,161页

共引文献2

同被引文献8

  • 1TOURNOY K G,DE SWERT K O,LECLERE P G,et al.Modulatory role of tachykinin NK1 receptor in cholinergic contraction of mouse trachea [J].Eur Respir J,2003,21(1):3-10.
  • 2FRYER A D,JACOBY D B.Muscarinic receptors and control of airway smooth muscle [J].Am J Respir Crit Care Med,1998,158(5 Pt 3):S154-160.
  • 3JACOBY D B,FRYER A D.Anticholinergic therapy for airway diseases [J].Life Sci,2001,68(22-23):2565-2572.
  • 4COULSON F R,FRYER A D.Muscarinic acetylcholine receptors and airway diseases [J].Pharmacol Ther,2003,98(1):59-69.
  • 5FRYDER A D,ADAMKO D J,YOST B L,et al.Effects of inflammatory cells on neuronal M2 muscarinic receptor function in the lung [J].Life Sci,1999,64(6-7):449-455.
  • 6MENCIU C,DUFLOS M,FOUCHARD F,et al.New N-(pyridin-4-yl)-(indol-3-yl) acetamides and propa-namides as antiallergic agents [J].J Med Chem,1999,42(4):638-648.
  • 7WU Y,FANG L B,YANG Q H.Nociceptin inhibits electric filed stimulation-induced cholinergic constrictions in rat airways [J].Acta Pharmacol Sin,2000,21(10):945-948.
  • 8季华,谢强敏,陈季强.吡拉米特与西拉米特的支气管扩张和抗变态反应作用比较[J].浙江大学学报(医学版),2003,32(4):274-278. 被引量:2

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部